1-5 of 5
Jing Gao
Close
Sort by
Journal Articles

Efficacy and Safety of BTK Inhibitors in Vitreoretinal Lymphoma: A Single-Center, Retrospective Analysis of 24 Patients

Jing Gao, Liang Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 3134.
https://doi.org/10.1182/blood-2023-180354
Published: 2023
Journal Articles

Pharmaocogenomic Characterization of MCL-1 Inhibitor Response and Resistance in Aggressive B-Cell Lymphomas

Michelle Wang, BSE, Tao Li, MD, Yuan Ren, PhD, Bijal Shah, MD, Tint Lwin, MD PhD, Jing Gao, PhD, Kenneth H. Shain, MD PhD, Wei Zhang, PhD, Xiaohong Zhao, MD PhD, Jianguo Tao, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-141407
Published: 2020
Journal Articles

Targeting Kinome Reprogramming for Overcoming Ibrutinib-Resistance (IR) in Mantle Cell Lymphoma (MCL)

Xiaohong Zhao, MD PhD, Huijuan Jiang, MD, Michelle Wang, Tao Li, MD, Jing Gao, PhD, Tint Lwin, MD PhD, Yuan Ren, PhD, Eduardo Sotomayor, MD, Bijal D. Shah, MD, Jianguo Tao, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2651.
https://doi.org/10.1182/blood-2018-99-116756
Published: 2018
Journal Articles

Computational Prediction of c- MYC Binding and Action by Integration of Multiple Data Sources.

Yili Chen, MS, Thomas W. Blackwell, Ph.D., Jing Gao, M.S., Anura Hewagama, Ph.D., Heather M. Grifka, B.S., Angel W. Lee, M.D. Ph.D., David J. States, M.D. Ph.D.
Journal: Blood
Blood (2006) 108 (11): 4345.
https://doi.org/10.1182/blood.V108.11.4345.4345
Published: 2006
Journal Articles

Interleukin-10 Suppresses IP-10 Gene Transcription by Inhibiting the Production of Class I Interferon

Julie M. Tebo, Hee Sun Kim, Jing Gao, David A. Armstrong, Thomas A. Hamilton
Journal: Blood
Blood (1998) 92 (12): 4742–4749.
https://doi.org/10.1182/blood.V92.12.4742
Published: 1998